Clinical Observation On Treatment With The Morning Stage Diabetics Nephropathy Of Deficiency Of Vital Energy With Blood Stasis Syndrome By BuShenMingMu Wan

Objective：Evaluating the clinical efficacy and security of BSMM Wan in treatingthe Morning Stage Diabetics Nephropathy。Methods：Case Source：The patients in first affiliated hospital of Henan Universityof TCM, endocrinology department. From April，2011to December，2013. In clinicalstudy, according to the international diagnosis criterion of DN (Mogensen’s criterionof stages)and TCM diagnosis criterion of deficiency of vital energy with Blood StasisSyndrome，70cases with the Morning Stage DN.70cases were randomly divided intotwo groups: The control group was given basic treatment, Lotensin10mg qd po. Thetreated group was given control groups, and BSMM Wan6g tid po. The treatment took8weeks.Observation Index: UAE, A/C,CystatinC(CysC), the blood rheologyindex,TCM syndrome score, Safety index.Results:Between the two groups, there was no statistical difference(P＞0.05)ingender, age, disease history, UAE,A/C, CysC,the blood rheology index beforetreatment. The UAE, A/C, CysC,the blood rheology index in treated group wasstatistically different(P＜0.01,P＜0.05) between the two group after treatment；Thenthe TCM syndrome score in treated group was statistically significant different(P＜0.01).Conclusion: In the basic of blood sugar controlled, BSMM Wan can improve thepatients symptoms and reduce UAE,A/C, CysC. The clinical result of treated groupwith BSMM Wan is statistically better than the control group one with Lotensin only.